Teva Pharmaceutical's total assets for Q4 2025 were $40.75B, an increase of 2.24% from the previous quarter. TEVA total liabilities were $32.84B for the fiscal quarter, a 0.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.